Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 27,659,439
- Share change
- +326,310
- Total reported value
- $3,802,977,476
- Put/Call ratio
- 116%
- Price per share
- $137.46
- Number of holders
- 274
- Value change
- -$846,440
- Number of buys
- 139
- Number of sells
- 160
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
4,320,832
|
$779,046,024 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
13%
|
3,943,165
|
$710,952,649 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.6%
|
2,825,282
|
$509,398,344 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
9.3%
|
2,731,000
|
$492,399,300 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.4%
from 13D/G
|
1,226,707
|
$221,175,272 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
3.2%
|
954,468
|
$172,090,580 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
2.5%
|
737,675
|
$133,002,803 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.3%
|
688,460
|
$124,129,338 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
612,353
|
$110,432,174 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
2%
|
575,506
|
$103,763,734 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
533,919
|
$96,270,219 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.8%
|
524,644
|
$94,593,313 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.5%
|
441,758
|
$79,648,967 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
410,861
|
$74,079,000 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
1.4%
|
400,744
|
$72,254,143 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
298,205
|
$53,766,539 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
259,995
|
$46,877,099 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.86%
|
254,486
|
$45,883,827 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
250,514
|
$45,167,674 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.79%
|
234,180
|
$42,222,654 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.79%
|
233,640
|
$42,125,292 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.75%
|
222,043
|
$40,034,353 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.63%
|
185,550
|
$33,455,000 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
169,179
|
$30,502,972 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.51%
|
151,225
|
$27,266,000 | — | 31 Mar 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.49%
|
145,337
|
$26,204,261 | — | 31 Mar 2025 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.48%
|
142,183
|
$25,635,595 | — | 31 Mar 2025 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.46%
|
136,000
|
$24,520,800 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.43%
|
126,337
|
$22,778,561 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
100,774
|
$18,169,551 | — | 31 Mar 2025 | |
| S Squared Technology, LLC |
13F
|
Company |
0.33%
|
97,215
|
$17,527,865 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
95,781
|
$17,269,314 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
92,561
|
$16,688,748 | — | 31 Mar 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.29%
|
85,809
|
$15,471,000 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.28%
|
81,999
|
$14,784,420 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
81,119
|
$14,625,756 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.27%
|
80,264
|
$14,471,599 | — | 31 Mar 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.25%
|
74,300
|
$13,396,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.25%
|
73,525
|
$13,256,558 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.25%
|
72,815
|
$13,128,545 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.23%
|
68,727
|
$12,391,455 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.23%
|
66,509
|
$11,991,575 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.22%
|
65,961
|
$11,892,767 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.22%
|
65,262
|
$11,766,739 | — | 31 Mar 2025 | |
| Decheng Capital LLC |
13F
|
Company |
0.22%
|
65,000
|
$11,719,500 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.22%
|
64,601
|
$11,647,561 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
60,508
|
$10,909,592 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
60,388
|
$10,887,956 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.2%
|
60,000
|
$10,818,000 | — | 31 Mar 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.2%
|
59,978
|
$10,814,033 | — | 31 Mar 2025 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q2 2025
As of 30 Jun 2025,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,659,439 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Capital World Investors, Soleus Capital Management, L.P., BRAIDWELL LP, Frazier Life Sciences Management, L.P., and Redmile Group, LLC.
This page lists
273
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
298
Q2 2025 holders
274
Holder diff
-24
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.